Search Results - "Bollino, Dominique"
-
1
CRF-amplified neuronal TLR4/MCP-1 signaling regulates alcohol self-administration
Published in Neuropsychopharmacology (New York, N.Y.) (01-05-2015)“…Alcohol dependence is a complex disorder that initiates with episodes of excessive alcohol drinking known as binge drinking. It has a 50-60% risk contribution…”
Get full text
Journal Article -
2
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia
Published in Blood (22-10-2024)“…Glutamine dependency has been shown to be a metabolic vulnerability in acute myeloid leukemia (AML). Prior studies using several in vivo AML models showed that…”
Get full text
Journal Article -
3
Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia
Published in Leukemia (01-07-2021)“…Complex karyotype acute myeloid leukemia (CK-AML) has a dismal outcome with current treatments, underscoring the need for new therapies. Here, we report…”
Get full text
Journal Article -
4
Dual targeting of glutamine and serine metabolism in acute myeloid leukemia
Published in Frontiers in oncology (16-04-2024)“…Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy characterized by disrupted blood cell production and function. Recent investigations…”
Get full text
Journal Article -
5
Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses
Published in Pathogens and disease (01-08-2016)“…Natural killer T (NKT) cells play a critical role in the host's innate immune response. CD1d-mediated presentation of glycolipid antigens to NKT cells has been…”
Get full text
Journal Article -
6
Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine
Published in Frontiers in oncology (12-12-2022)“…The impact of asparaginases on plasma asparagine and glutamine is well established. However, the effect of asparaginases, particularly those derived from (also…”
Get full text
Journal Article -
7
Immunotherapeutic strategies targeting natural killer T cell responses in cancer
Published in Immunogenetics (New York) (01-08-2016)“…Natural killer T (NKT) cells are a unique subset of lymphocytes that bridge the innate and adaptive immune system. NKT cells possess a classic αβ T cell…”
Get full text
Journal Article -
8
Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinoma
Published in Cancer & metabolism (30-06-2024)“…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease without meaningful therapeutic options beyond the first salvage therapy. Targeting PDAC…”
Get full text
Journal Article -
9
Therapeutic targeting of the immunosuppressive axis in ovarian cancer using dietary supplements
Published in The Journal of immunology (1950) (01-05-2019)“…Abstract Ovarian cancer is the deadliest gynecologic malignancy worldwide and mortality rates have remained steady despite advances in treatment. A major…”
Get full text
Journal Article -
10
Valproic acid induces neuronal cell death through a novel calpain‐dependent necroptosis pathway
Published in Journal of neurochemistry (01-04-2015)“…A growing body of evidence indicates that valproic acid (VPA), a histone deacetylase inhibitor used to treat epilepsy and mood disorders, has histone…”
Get full text
Journal Article -
11
Chimeric antigen receptor engineered natural killer and natural killer T cells for cancer immunotherapy
Published in Translational research : the journal of laboratory and clinical medicine (01-09-2017)“…Abstract Natural killer (NK) cells of the innate immune system and natural killer T (NKT) cells, which have roles in both the innate and adaptive responses,…”
Get full text
Journal Article -
12
Long-Acting E. coli-Derived Asparaginase Potentiates the Anti-Leukemic Effect of BCL2 Inhibition, but Not MCL1 Inhibition, in Preclinical Models of Acute Myeloid Leukemia
Published in Blood (02-11-2023)“…Background: Asparaginases are enzymes that deplete circulating asparagine and glutamine from plasma and can therefore be used therapeutically for cancers that…”
Get full text
Journal Article -
13
Targeting Serine Biosynthesis in Combination with the Modulation of Glutamine Metabolism Enhances Cellular Cytotoxicity in Acute Myeloid Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
14
ΔPK oncolytic activity includes modulation of the tumour cell milieu
Published in Journal of general virology (01-02-2016)“…Oncolytic virotherapy is a unique cancer therapeutic that encompasses tumour cell lysis through both virus replication and programmed cell death (PCD)…”
Get full text
Journal Article -
15
The oncolytic virus ΔPK has multimodal anti-tumor activity
Published in Pathogens and disease (01-07-2016)“…Oncolytic viruses (OVs) are an emerging cancer therapeutic, with a near complete absence of serious adverse effects. However, clinical efficacy is relatively…”
Get full text
Journal Article -
16
Pegcrisantaspase (PegC) Induces an Increase in Plasma Threonine in Patients With Acute Myeloid Leukemia (AML)
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)Get full text
Journal Article -
17
AML-498 Pegcrisantaspase (PegC) Induces an Increase in Plasma Threonine in Patients With Acute Myeloid Leukemia (AML)
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…Glutamine depletion has been reported to be a therapeutic vulnerability in AML that is thought to be mediated by indirect inhibition of the mTOR pathway. We…”
Get full text
Journal Article -
18
-
19
Targeting the VEGF/GD3 immunosuppressive axis in ovarian cancer
Published in The Journal of immunology (1950) (01-05-2017)“…Abstract Ovarian cancer is the fifth leading cause of cancer deaths among women, thereby accounting for more deaths than any other cancer of the female…”
Get full text
Journal Article -
20
Overcoming Venetoclax (Ven) Resistance through Glutamine (Gln) Depletion: Final Analysis of the Phase 1 Trial of Ven and Pegcrisantaspase (PegC) Combination in Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML)
Published in Blood (02-11-2023)“…Background: Ven-based therapies have been an advancement in the front-line treatment of AML; however development of resistance is common and the efficacy of…”
Get full text
Journal Article